OTC - ACTIVE INGREDIENT SECTION
Niacinamide 2%
Adenosine 0.04%
SHEZA GUSL FIRMING MASK PACK
- Manufacturer
- PISATAP
- Effective date
- 2013-08-09
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:36:30
Label at a glance#
ProductSHEZA GUSL FIRMING MASK PACK
Active ingredientNiacinamide, Adenosine
Label structure11 sections
Label contents#
Full prescribing information#
OTC - PURPOSE SECTION
Helps to improve skin firmness
INSTRUCTIONS FOR USE SECTION
Apply to desired area such as face or neck by rolling the ball as if massaging. When lifting shows and product is completely dried after 2-3 minutes, wash off with a little amount of lukewarm water, and it absorb into the skin by softly patting.
When used in the morning, thoroughly wash off with lukewarm water before apply makeup.
OTC - ASK DOCTOR SECTION
If rash or irritation occurs, stop use and ask a doctor.
OTC - WHEN USING SECTION
When using the product, keep out of eyes. Rinse with lukewarm water to remove.
INACTIVE INGREDIENT SECTION
Soluble collagen, water, glycerin, dipropylene Glycol, Sodium Hyaluronate, Sodium PCA, Alcohol, Trehalose, Decyl Glucoside, Sodium polyacrylate, PPG-26-Buteth-26, PEG-40 Hydrogenated Castor Oil, Daemonorops draco extract, Caffeoyl sh-Octapeptide-4, sh-Decapeptide-9, Galactomyces Ferment Filtrate, Bifida ferment filtrate, Saccharomyces/Copper Ferment, Saccharomyces/Platinum Ferment, Lavendula Angustifolia (Lavender) Extract, Monarda Didyma Leaf Extract, Freesia Refracta Extract,Mentha piperita (peppermint) leaf extract, Chamomilla recutita (Matricaria) flower extract, Rosmarinus Officinalis (Rosemary) leaf extract, Panthenol, Dipotassium Glycyrrhizate, Aloe Barbadensis Leaf Juice, Fragrance, 1-2-hexanediol, Caprylhydroxamic Acid, Disodium EDTA
WARNINGS SECTION
For External Use Only.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
INDICATIONS & USAGE SECTION
Helps to improve firmness.
Application is possible on all desired areas including face, neck, and hands, through a simple method of rolling an antibacterial marble around the area.
It allows comfortable movement after applying pack.
DOSAGE & ADMINISTRATION SECTION
Apply to desired areas such as face or neck by rolling the ball as if massaging.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| ADENOSINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 8809320242280 | GTIN-13: 8809320242280 EAN-13: 8809320242280 GTIN storage (14 digits): 08809320242280 | GUSL FIRMING MASK PACK.jpg |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d676a241-be05-4740-b3ee-1a5f2ed422d2 | Product name | 4 | 20180615 |
| dd8bd48f-20d6-43c7-b471-3ae872868afa | Product name | 3 | 20180125 |
| d41954ff-bc63-4b2c-aba0-9146707659d7 | Product name | 2 | 20151117 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 59532-001-02 | 2019-11-27 | C162847 | 48780-1 | 9855d018-eb97-cd31-e053-dbdaa90ab51a | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59532-001-01 | SHEZA GUSL FIRMING MASK PACK | 50 g in 1 CONTAINER | CREAM | 50 | 1 | |
| 59532-001-02 | SHEZA GUSL FIRMING MASK PACK | 1 in 1 CARTON | CREAM | 1 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Adenosine | ACTIVE INGREDIENT | K72T3FS567 | 1 | |
| Niacinamide | ACTIVE INGREDIENT | 25X51I8RD4 | 1 | |
| Adenosine | ACTIVE MOIETY | K72T3FS567 | 1 | |
| Niacinamide | ACTIVE MOIETY | 25X51I8RD4 | 1 | |
| 1,2-Hexanediol | INACTIVE INGREDIENT | TR046Y3K1G | 1 | |
| Alcohol | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| CAPRYLHYDROXAMIC ACID | INACTIVE INGREDIENT | UPY805K99W | 1 | |
| CHAMOMILE | INACTIVE INGREDIENT | FGL3685T2X | 1 | |
| DAEMONOROPS DRACO WHOLE | INACTIVE INGREDIENT | 1C8HA8O22C | 1 | |
| Decyl Glucoside | INACTIVE INGREDIENT | Z17H97EA6Y | 1 | |
| Dipropylene Glycol | INACTIVE INGREDIENT | E107L85C40 | 1 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 1 | |
| FREESIA ALBA FLOWER | INACTIVE INGREDIENT | 33X293N6JT | 1 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCYRRHIZINATE DIPOTASSIUM | INACTIVE INGREDIENT | CA2Y0FE3FX | 1 | |
| HYALURONATE SODIUM | INACTIVE INGREDIENT | YSE9PPT4TH | 1 | |
| LAVANDULA ANGUSTIFOLIA FLOWERING TOP | INACTIVE INGREDIENT | 9YT4B71U8P | 1 | |
| MENTHA PIPERITA LEAF | INACTIVE INGREDIENT | A389O33LX6 | 1 | |
| MONARDA DIDYMA LEAF | INACTIVE INGREDIENT | JY15982UBB | 1 | |
| Panthenol | INACTIVE INGREDIENT | WV9CM0O67Z | 1 | |
| POLYOXYL 40 HYDROGENATED CASTOR OIL | INACTIVE INGREDIENT | 7YC686GQ8F | 1 | |
| PORK COLLAGEN | INACTIVE INGREDIENT | I8442U2G7J | 1 | |
| PPG-26-Buteth-26 | INACTIVE INGREDIENT | 2II1K6TZ4P | 1 | |
| ROSEMARY | INACTIVE INGREDIENT | IJ67X351P9 | 1 | |
| SACCHAROMYCES CEREVISIAE | INACTIVE INGREDIENT | 978D8U419H | 1 | |
| SODIUM POLYACRYLATE (8000 MW) | INACTIVE INGREDIENT | 285CYO341L | 1 | |
| SODIUM PYRROLIDONE CARBOXYLATE | INACTIVE INGREDIENT | 469OTG57A2 | 1 | |
| Trehalose | INACTIVE INGREDIENT | B8WCK70T7I | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- SHEZA GUSL FIRMING MASK PACK
- Niacinamide, Adenosine
- Niacinamide
- Adenosine
- PORK COLLAGEN
- Water
- Glycerin
- Dipropylene Glycol
- HYALURONATE SODIUM
- SODIUM PYRROLIDONE CARBOXYLATE
- Alcohol
- Trehalose
- Decyl Glucoside
- SODIUM POLYACRYLATE (8000 MW)
- PPG-26-Buteth-26
- POLYOXYL 40 HYDROGENATED CASTOR OIL
- DAEMONOROPS DRACO WHOLE
- SACCHAROMYCES CEREVISIAE
- LAVANDULA ANGUSTIFOLIA FLOWERING TOP
- MONARDA DIDYMA LEAF
- FREESIA ALBA FLOWER
- MENTHA PIPERITA LEAF
- CHAMOMILE
- ROSEMARY
- Panthenol
- GLYCYRRHIZINATE DIPOTASSIUM
- ALOE VERA LEAF
- 1,2-Hexanediol
- CAPRYLHYDROXAMIC ACID
- EDETATE DISODIUM
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 59532-001 | 59532-001-01, 59532-001-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / TOPICAL | 1 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | OINTMENT / TOPICAL | 1 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | DROPS / AURICULAR (OTIC) | 0.05 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LIQUID / INTRAVENOUS | 0.03 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SYSTEM / TOPICAL | 126 mg | ||
| POLYOXYL 40 HYDROGENATED CASTOR OIL | POLYOXYL 40 HYDROGENATED CASTOR OIL | 7YC686GQ8F | SOLUTION / ORAL | 3240 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SPRAY, METERED / NASAL | 4 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET / ORAL | 100 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM / TOPICAL | 14 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | AEROSOL, FOAM / TOPICAL | 0.05 %w/w | ||
| POLYOXYL 40 HYDROGENATED CASTOR OIL | POLYOXYL 40 HYDROGENATED CASTOR OIL | 7YC686GQ8F | SOLUTION/ DROPS / OPHTHALMIC | 0.53 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, DELAYED RELEASE / ORAL | 100 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SUSPENSION / INTRAMUSCULAR | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CAPSULE / ORAL | 5 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | AEROSOL, FOAM / RECTAL | 2 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / AURICULAR (OTIC) | 0.01 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INFILTRATION | 6 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAVITREAL | 23 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVASCULAR | 0.48 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRA-ARTICULAR | 0.05 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / ORAL | 30 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRA-ARTICULAR | 23 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| db430c4e-6e61-4bf3-b21d-c6f97236834e | f398bf10-89c8-4928-814b-1b59ed4085c7 | 2013-08-09 | Warnings | db430c4e-6e61-4bf3-b21d-c6f97236834e f398bf10-89c8-4928-814b-1b59ed4085c7 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.